David A. Siegel Liva Nova PLC Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Liva Nova PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 214,545 shares of LIVN stock, worth $8.78 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
214,545
Previous 86,345
148.47%
Holding current value
$8.78 Million
Previous $4.53 Million
119.17%
% of portfolio
0.02%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding LIVN
# of Institutions
274Shares Held
55.2MCall Options Held
140KPut Options Held
44.5K-
Black Rock Inc. New York, NY6.9MShares$283 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.75MShares$195 Million0.17% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.05MShares$125 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$96.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.1MShares$85.9 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.19B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...